Loading viewer...
investor_presentation
Format: PDF investor_presentation
Inovio presents its DNA medicine platform and clinical pipeline as of May 2020, highlighting achievements including the first DNA medicine in Phase 3 trials (VGX-3100) for cervical dysplasia and first dMAb in Phase 1 for Zika. The company showcases immune response data from over 2,000 patients and its proprietary smart device delivery technology.
presentation
Pacific Life Global Funding II Investor Presentation 2020
investor_presentationinvestor_presentation
26 Pages
Pacific Mutual Holding Company
ZF Commercial Vehicle Control Systems India 2024 Presentation
investor_presentationinvestor_presentation
36 Pages
ZF Commercial Vehicle Control Systems India Limited